CENTRAL TRUST Co grew its position in Clorox Co (NYSE:CLX) by 7.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 42,801 shares of the company’s stock after purchasing an additional 2,959 shares during the period. CENTRAL TRUST Co’s holdings in Clorox were worth $6,366,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the company. Janus Henderson Group PLC lifted its position in Clorox by 8,008.5% during the 2nd quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock worth $176,340,000 after buying an additional 1,307,153 shares in the last quarter. APG Asset Management N.V. lifted its position in Clorox by 30.9% during the 3rd quarter. APG Asset Management N.V. now owns 1,301,915 shares of the company’s stock worth $171,736,000 after buying an additional 307,700 shares in the last quarter. Acadian Asset Management LLC lifted its position in Clorox by 33.9% during the 4th quarter. Acadian Asset Management LLC now owns 1,049,445 shares of the company’s stock worth $156,092,000 after buying an additional 265,892 shares in the last quarter. Renaissance Technologies LLC lifted its position in Clorox by 24.5% during the 2nd quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock worth $178,728,000 after buying an additional 263,700 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in Clorox by 63.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 417,347 shares of the company’s stock worth $54,269,000 after buying an additional 161,555 shares in the last quarter. Institutional investors own 72.76% of the company’s stock.

Clorox Co (NYSE CLX) traded up $0.62 during trading on Tuesday, reaching $144.48. 734,000 shares of the company’s stock were exchanged, compared to its average volume of 812,929. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02. Clorox Co has a 52 week low of $118.87 and a 52 week high of $150.40. The firm has a market cap of $18,460.00, a P/E ratio of 26.51, a PEG ratio of 3.76 and a beta of 0.42.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. Clorox had a net margin of 11.84% and a return on equity of 161.59%. The company had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the prior year, the company posted $1.36 EPS. The company’s revenue was up 4.0% compared to the same quarter last year. research analysts expect that Clorox Co will post 5.7 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a yield of 2.33%. Clorox’s payout ratio is presently 61.65%.

Several research analysts recently issued reports on CLX shares. Deutsche Bank started coverage on shares of Clorox in a research report on Wednesday, December 13th. They set a “hold” rating and a $142.00 price target on the stock. Wells Fargo & Co reiterated a “hold” rating and set a $130.00 price target on shares of Clorox in a research report on Wednesday, December 13th. Royal Bank of Canada reiterated a “hold” rating and set a $115.00 price target on shares of Clorox in a research report on Sunday, October 8th. Consumer Edge upgraded shares of Clorox from a “neutral” rating to an “outperform” rating in a research report on Friday, November 10th. Finally, Morgan Stanley reduced their price target on shares of Clorox from $138.00 to $128.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 2nd. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the company. Clorox currently has an average rating of “Hold” and a consensus price target of $134.33.

In other news, SVP Michael R. Costello sold 10,574 shares of the company’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the sale, the senior vice president now directly owns 34,867 shares of the company’s stock, valued at approximately $4,742,260.67. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the sale, the senior vice president now directly owns 10,896 shares of the company’s stock, valued at $1,421,492.16. The disclosure for this sale can be found here. Corporate insiders own 1.00% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2018/01/23/clorox-co-clx-stake-raised-by-central-trust-co.html.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.